Compare Bristol-Myers Squibb Co (BMY) vs 3M Company (MMM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs 3M Company — how do they compare? Bristol-Myers Squibb Co trades at $63.63 (market cap $129.94B), while 3M Company trades at $182.16 (market cap $94.44B). The key difference: Bristol-Myers Squibb Co is the larger of the two by market cap, and Bristol-Myers Squibb Co pays the higher dividend (3.96%). Which is the better fit depends on your goals.
| BMY | MMM | |
|---|---|---|
Market Cap | $129.94B | $94.44B |
Sector | Health | Industrials |
52-Week High | $65.89 | $183.13 |
52-Week Low | $42.60 | $141.10 |
Enterprise Value | $163.92B | $103.67B |
Dividend Yield | 3.96% | 1.7% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About 3M Company
3M Company conducts operations in electronics, telecommunications, industrial, consumer and office, health care, safety, and other markets. The Company businesses share technologies, manufacturing operations, marketing channels, and other resources. 3M serves customers worldwide.
Read more on MMM →
